Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Sex differences in Alzheimer’s-related Tau biomarkers and a mediating effect of testosterone

Research Square(2020)10.21203/rs.3.rs-23746/v1Source: DataRank Database

Sex differences in Alzheimer’s-related Tau biomarkers and a mediating effect of testosterone is a research paper published in Research Square (2020). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (49)IDs (PubMed, OpenAlex)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Matthew S. Panizzon ORCID,Xu Chen ORCID,Murray Andrews ORCID,Douglas Galasko ORCID,Sarah J. Banks ORCID

Live enrichment

PubMed:20819859 OpenAlex:https://openalex.org/W4252255298

National Institutes of Health

Grant: 5P50AG005131-25

CORE--CLINICAL

National Institutes of Health

Grant: 1U01AG024904-01

Alzheimers Disease Neuroimaging Initiative

Canadian Institutes of Health Research

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5R01AG056410-03

Effects of Androgen Deprivation Therapy on Preclinical Symptoms of Alzheimer's Disease

National Institutes of Health

Grant: 1R01AG049810-01A1

Re-visiting Methods for MCI Diagnosis to Improve Biomarker and Trial Findings

greenLicense: cc-by

repositoryhttps://www.researchsquare.com/article/rs-23746/v1.pdf?c=1631847913000

publisherhttps://www.researchsquare.com/article/rs-23746/v1

publisherhttps://www.researchsquare.com/article/rs-23746/v1.html

repositoryhttps://doi.org/10.21203/rs.3.rs-23746/v1

Fields of Study

Stress Responses and CortisolAlzheimer's disease research and treatmentsTryptophan and brain disorders03 medical and health sciences0302 clinical medicine

Keywords

Testosterone (patch)PsychologyInternal medicineEndocrinologyNeuroscienceMedicineMaleAgingPhysiologyApolipoprotein E4610tau ProteinsNeurodegenerativeAlzheimer's DiseaseAlzheimer DiseaseSex Hormone-Binding GlobulinAcquired Cognitive Impairment80 and overGenetics2.1 Biological and endogenous factorsQP1-981HumansTestosteroneAgedAged, 80 and overSex CharacteristicsResearchNeurosciencesRAlzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)Alzheimer’s Disease Neuroimaging InitiativeBiological SciencesBrain DisordersPhosphorylated-TauCerebrospinal fluidNeurologicalWomen's HealthDementiaSexFemaleBiochemistry and Cell BiologyAlzheimer’s diseaseAPOEBiomarkers

Sustainable Development Goals

SDG 3: 3. Good healthSDG 10: 10. No inequalitySDG 0: Good health and well-being